BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4092192)

  • 1. Potentiation and protection of doxorubicin cytotoxicity by cellular glutathione modulation.
    Russo A; Mitchell JB
    Cancer Treat Rep; 1985 Nov; 69(11):1293-6. PubMed ID: 4092192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of bleomycin cytotoxicity by glutathione depletion or elevation.
    Russo A; Mitchell JB; McPherson S; Friedman N
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1675-8. PubMed ID: 6207156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation response of Chinese hamster cells after elevation of intracellular glutathione levels.
    Russo A; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1243-7. PubMed ID: 6469745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of intracellular glutathione in antineoplastic chemotherapy.
    Russo A; Carmichael J; Friedman N; DeGraff W; Tochner Z; Glatstein E; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1347-54. PubMed ID: 3531114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of buthionine sulfoximine on toxicity of verapamil and doxorubicin to multidrug resistant cells and to mice.
    Ford JM; Yang JM; Hait WN
    Cancer Res; 1991 Jan; 51(1):67-72. PubMed ID: 1988108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione and cellular response of ACNU-resistant rat glioma sublines to drugs and radiation.
    Saito Y; Nakada Y; Hotta T; Mikami T; Kurisu K; Yamada K; Kiya K; Kawamoto K; Uozumi T
    Int J Cancer; 1991 Jul; 48(6):861-5. PubMed ID: 1860733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.
    Dusre L; Mimnaugh EG; Myers CE; Sinha BK
    Cancer Res; 1989 Feb; 49(3):511-5. PubMed ID: 2535960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs.
    Russo A; DeGraff W; Friedman N; Mitchell JB
    Cancer Res; 1986 Jun; 46(6):2845-8. PubMed ID: 2421885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.
    Hamilton TC; Winker MA; Louie KG; Batist G; Behrens BC; Tsuruo T; Grotzinger KR; McKoy WM; Young RC; Ozols RF
    Biochem Pharmacol; 1985 Jul; 34(14):2583-6. PubMed ID: 4040369
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo selective modulation of tissue glutathione in a rat mammary carcinoma model.
    Baruchel S; Wang T; Farah R; Jamali M; Batist G
    Biochem Pharmacol; 1995 Oct; 50(9):1505-8. PubMed ID: 7503802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of glutathione and glutathione peroxidase in the protection against endothelial cell injury induced by 15-hydroperoxyeicosatetraenoic acid.
    Ochi H; Morita I; Murota S
    Arch Biochem Biophys; 1992 May; 294(2):407-11. PubMed ID: 1314541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione depletion greatly reduces neocarzinostatin cytotoxicity in Chinese hamster V79 cells.
    DeGraff WG; Russo A; Mitchell JB
    J Biol Chem; 1985 Jul; 260(14):8312-5. PubMed ID: 3159728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of intracellular glutathione protects endothelial cells against oxidant damage.
    Tsan MF; Danis EH; Del Vecchio PJ; Rosano CL
    Biochem Biophys Res Commun; 1985 Feb; 127(1):270-6. PubMed ID: 3977922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The generation of oxygen radicals: a positive signal for lymphocyte activation.
    Fidelus RK
    Cell Immunol; 1988 Apr; 113(1):175-82. PubMed ID: 3365770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of buthionine sulfoximine and the stabilization of DNA-topoisomerase II complexes by doxorubicin.
    Bonner JA; Christianson TJ; Lawrence TS
    Int J Radiat Oncol Biol Phys; 1992; 22(3):519-23. PubMed ID: 1310496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of gamma-glutamyl cycle and glutathione levels in rat mammary gland explants.
    Puente J; Devoto MA; Sapag-Hagar M
    Int J Tissue React; 1986; 8(2):105-10. PubMed ID: 2870991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of cellular glutathione elevation on the oxygen enhancement ratio.
    Russo A; Mitchell JB; Finkelstein E; DeGraff WG; Spiro IJ; Gamson J
    Radiat Res; 1985 Aug; 103(2):232-9. PubMed ID: 4023177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between cellular glutathione level and susceptibility to LAK killing in human pharyngeal carcinoma cell line.
    Noda I; Fujieda S; Saito H; Tanaka N; Sugimoto C; Hoshino T; Yagita M
    Anticancer Res; 1994; 14(3A):1117-20. PubMed ID: 8074461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of L-2-oxothiazolidine on glutathione levels in cultured mammalian cells.
    Weitberg AB
    Mutat Res; 1987; 191(3-4):189-91. PubMed ID: 3627156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of intracellular glutathione concentrations alters lymphocyte activation and proliferation.
    Fidelus RK; Ginouves P; Lawrence D; Tsan MF
    Exp Cell Res; 1987 Jun; 170(2):269-75. PubMed ID: 3595735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.